About conmed corp. - CNMD
CONMED Corp. is a medical technology company, which engages in providing devices and equipment for surgical procedures. Its products include AirSeal and insufflation, allograft cartilage and tissue, arthroplasty, biliary and endoscopic ultrasound, biomedical sensors and electrodes, biopsy and polypectomy, dilators and accessories, electrosurgical units, fixation devices, hemostasis, implants and suture anchors, infection prevention, patient positioning, and related products. The company was founded by Eugene R. Corasanti in 1970 and is headquartered in Largo, FL.
CNMD At a Glance
CONMED Corp.
11311 Concept Boulevard
Largo, Florida 33773
| Phone | 1-727-392-6464 | Revenue | 1.37B | |
| Industry | Medical Specialties | Net Income | 47.06M | |
| Sector | Health Technology | 2025 Sales Growth | 5.509% | |
| Fiscal Year-end | 12 / 2026 | Employees | 3,900 | |
| View SEC Filings |
CNMD Valuation
| P/E Current | 18.112 |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | 26.877 |
| Price to Sales Ratio | 0.92 |
| Price to Book Ratio | 1.217 |
| Price to Cash Flow Ratio | 7.41 |
| Enterprise Value to EBITDA | 10.913 |
| Enterprise Value to Sales | 1.536 |
| Total Debt to Enterprise Value | 0.42 |
CNMD Efficiency
| Revenue/Employee | 352,434.615 |
| Income Per Employee | 12,065.385 |
| Receivables Turnover | 5.546 |
| Total Asset Turnover | 0.593 |
CNMD Liquidity
| Current Ratio | 2.136 |
| Quick Ratio | 1.007 |
| Cash Ratio | 0.13 |
CNMD Profitability
| Gross Margin | 52.774 |
| Operating Margin | 10.268 |
| Pretax Margin | 5.174 |
| Net Margin | 3.423 |
| Return on Assets | 2.032 |
| Return on Equity | 4.715 |
| Return on Total Capital | 2.45 |
| Return on Invested Capital | 2.469 |
CNMD Capital Structure
| Total Debt to Total Equity | 85.905 |
| Total Debt to Total Capital | 46.209 |
| Total Debt to Total Assets | 38.159 |
| Long-Term Debt to Equity | 85.003 |
| Long-Term Debt to Total Capital | 45.724 |